Jeffrey Lin

2.2k total citations
39 papers, 1.6k citations indexed

About

Jeffrey Lin is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Jeffrey Lin has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 9 papers in Molecular Biology. Recurrent topics in Jeffrey Lin's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Viral-associated cancers and disorders (5 papers). Jeffrey Lin is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Viral-associated cancers and disorders (5 papers). Jeffrey Lin collaborates with scholars based in United States, Spain and Germany. Jeffrey Lin's co-authors include Elliott Kieff, Erle S. Robertson, Eric Johannsen, Ravi Salgia, Bruce E. Johnson, Gautam Maulik, Elizabeth Murphy, Junhui Sun, Charles Steenbergen and Eric D. Hsi and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

In The Last Decade

Jeffrey Lin

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Lin United States 19 794 558 381 284 237 39 1.6k
Beatriz Martı́nez-Delgado Spain 28 601 0.8× 1.2k 2.1× 522 1.4× 260 0.9× 84 0.4× 81 2.2k
Ludwig Wilkens Germany 27 575 0.7× 1.2k 2.1× 261 0.7× 240 0.8× 247 1.0× 77 2.5k
Céline Callens France 27 670 0.8× 1.0k 1.9× 355 0.9× 160 0.6× 187 0.8× 83 2.2k
Oliver Bechter Belgium 24 603 0.8× 767 1.4× 184 0.5× 238 0.8× 121 0.5× 95 1.7k
Iacopo Petrini Italy 27 1.0k 1.3× 884 1.6× 280 0.7× 193 0.7× 154 0.6× 91 2.5k
Yuichi Shiraishi Japan 26 348 0.4× 1.2k 2.2× 253 0.7× 233 0.8× 87 0.4× 98 2.1k
Dorina Gui United States 23 345 0.4× 862 1.5× 113 0.3× 211 0.7× 100 0.4× 52 1.7k
Chun‐Kui Shao China 26 808 1.0× 646 1.2× 229 0.6× 315 1.1× 193 0.8× 75 1.8k
Hirotaka Matsui Japan 28 368 0.5× 1.4k 2.6× 145 0.4× 270 1.0× 173 0.7× 116 2.3k
Antonella Argentiero Italy 23 794 1.0× 596 1.1× 149 0.4× 406 1.4× 162 0.7× 48 1.6k

Countries citing papers authored by Jeffrey Lin

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Lin more than expected).

Fields of papers citing papers by Jeffrey Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Lin. The network helps show where Jeffrey Lin may publish in the future.

Co-authorship network of co-authors of Jeffrey Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Lin. A scholar is included among the top collaborators of Jeffrey Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Lin. Jeffrey Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurinovich, Anastasia, et al.. (2024). Patterns and risk factors of immune-related adverse events in a real-world cohort with lung cancer receiving immunotherapy.. Journal of Clinical Oncology. 42(16_suppl). 12130–12130.
2.
Han, Xu, Ali Zhang, Pan Wang, et al.. (2024). Pleckstrin-2 Mediates the Activation of AKT in Prostate Cancer and Is Repressed by Androgen Receptor. American Journal Of Pathology. 194(10). 1986–1996. 5 indexed citations
3.
Cubo, Esther, Sheng Luo, Pablo Martínez‐Martín, et al.. (2023). Expanded and Independent Spanish Validation of the MDS‐Non Motor Rating Scale. Movement Disorders Clinical Practice. 10(4). 586–595. 1 indexed citations
4.
Hu, Xiao, et al.. (2023). Real-world data on immune-checkpoint inhibitors use and immune-related adverse events in lung cancer.. JCO Oncology Practice. 19(11_suppl). 156–156. 1 indexed citations
5.
Kaasinen, Valtteri, Filip Scheperjans, Mikko Kärppä, et al.. (2021). Validation of the Finnish Version of the Unified Dyskinesia Rating Scale. European Neurology. 84(6). 444–449.
6.
Cai, Louis, Jeffrey Lin, Matthew R. Starr, et al.. (2021). PRO score: predictive scoring system for visual outcomes after rhegmatogenous retinal detachment repair. British Journal of Ophthalmology. 107(4). 555–559. 5 indexed citations
7.
Lin, Jeffrey, et al.. (2021). Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change. Movement Disorders. 36(12). 2853–2861. 10 indexed citations
8.
Lim, Ilhan, Maria Liza Lindenberg, Esther Mena, et al.. (2019). 18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab. European Journal of Nuclear Medicine and Molecular Imaging. 47(1). 178–184. 7 indexed citations
9.
Lin, Jeffrey, et al.. (2019). Successful use of the Unified Dyskinesia Rating Scale regardless of PD- or dyskinesia-duration. Parkinsonism & Related Disorders. 67. 113–116. 1 indexed citations
10.
11.
Bagheri, Mohammadhadi, Mark A. Ahlman, Liza Lindenberg, et al.. (2017). Advances in medical imaging for the diagnosis and management of common genitourinary cancers. Urologic Oncology Seminars and Original Investigations. 35(7). 473–491. 37 indexed citations
12.
Nakashima, Megan O., Lisa Durkin, Juraj Bodo, et al.. (2014). Utility and Diagnostic Pitfalls of SOX11 Monoclonal Antibodies in Mantle Cell Lymphoma and Other Lymphoproliferative Disorders. Applied immunohistochemistry & molecular morphology. 22(10). 720–727. 15 indexed citations
13.
Deng, Ruishu, Kaniel Cassady, Xiaofan Li, et al.. (2014). B7H1/CD80 Interaction Augments PD-1–Dependent T Cell Apoptosis and Ameliorates Graft-versus-Host Disease. The Journal of Immunology. 194(2). 560–574. 58 indexed citations
14.
Achille, Nicholas J., Jeffrey Lin, Aravinda Kuntimaddi, et al.. (2014). Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4. Leukemia Research. 38(11). 1309–1315. 5 indexed citations
15.
Ondrejka, Sarah L., et al.. (2012). Phospho-ERKTHR202/Tyr214 Is Overexpressed in Hairy Cell Leukemia and Is a Useful Diagnostic Marker in Bone Marrow Trephine Sections. The American Journal of Surgical Pathology. 37(2). 305–308. 12 indexed citations
16.
Lin, Jeffrey & Charles S. Hemenway. (2010). Hsp90 Directly Modulates the Spatial Distribution of AF9/MLLT3 and Affects Target Gene Expression. Journal of Biological Chemistry. 285(16). 11966–11973. 11 indexed citations
17.
Lin, Jeffrey, Charles Steenbergen, Elizabeth Murphy, & Junhui Sun. (2009). Estrogen Receptor-β Activation Results in S-Nitrosylation of Proteins Involved in Cardioprotection. Circulation. 120(3). 245–254. 117 indexed citations
18.
Yan, Pearlly S., Thomas Efferth, Hsiao‐Ling Chen, et al.. (2002). Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods. 27(2). 162–169. 44 indexed citations
19.
Wang, Wenlan, Martin Sattler, Shalini Verma, et al.. (2000). Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene. 19(31). 3521–3528. 209 indexed citations
20.
Li, Weiguo, Steven C. Shivers, Jeffrey Lin, et al.. (2000). Clinical Relevance of Molecular Staging for Melanoma. Annals of Surgery. 231(6). 795–803. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Martı́nez-Delgado Breakdown of academic impact, for papers by Ludwig Wilkens Breakdown of academic impact, for papers by Céline Callens Breakdown of academic impact, for papers by Oliver Bechter Breakdown of academic impact, for papers by Iacopo Petrini Breakdown of academic impact, for papers by Yuichi Shiraishi Breakdown of academic impact, for papers by Dorina Gui Breakdown of academic impact, for papers by Chun‐Kui Shao Breakdown of academic impact, for papers by Hirotaka Matsui Breakdown of academic impact, for papers by Antonella Argentiero
Rankless by CCL
2026